| Message: |
Product Name: Ledipasvir (GS-5885)
Ledipasvir Synonyms: GS 5885;GS5885;GS-5885;Ledipasvir;GS-5885/Ledipasvir;gs-5885/gs5885;Ledipasvir / GS 5885;GS 588
Ledipasvir CAS: 1256388-51-8
Ledipasvir MF: C49H54F2N8O6
Ledipasvir Molecular Weight: 889.0
Ledipasvir Product Categories: API
Ledipasvir Categories: NS5A inhibitors;Fluorenes;Carbamates;Benzimidazoles;Cyclopropanes;Imidazoles;Breakthrough therapy
Ledipasvir Purity : 98%
Ledipasvir Solubility DMSO
Ledipasvir Storage at -20°C
Ledipasvir Appearance : White powders
Ledipasvir Package : 50g/foil bag
Ledipasvir Usage : Ledipasvir is most commonly used in combination with sofosbuvir for treatment in chronic hepatitis C genotype 1 patients.
This drug has been tested and shown efficacy in treatment-naive and treatment experienced patients.
Ledipasvir Product Description :
Ledipasvir (formerly GS-5885) is a drug for the treatment of hepatitis C that was developed by Gilead Sciences.After completing Phase III clinical trials, on February 10, 2014 Gilead filed for U.S. approval of a ledipasvir/sofosbuvir fixed-dose combination tablet for genotype 1 hepatitis C. The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin.
|
my account
